{"store":{"baseInfo":{"podcastTitle":"DDN Dialogues","slug":"DDNDialogues","podcastDescription":"DDN Dialogues is a new podcast from Drug Discovery News. Join us as we explore the stories behind the latest advances in drug discovery research.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/16749498/69174_DDN_Dialogues_logo_for_Apple_Podcast_KR_1400x1400_p8nnwc.jpg","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/16749498/69174_DDN_Dialogues_logo_for_Apple_Podcast_KR_1400x1400_p8nnwc_1200x628.jpg?s=ae732289e934f2a1258dd70ca1bf8ddf&e=jpg","podcastUrl":"https://DDNDialogues.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/DDNDialogues/feed.xml","theme":"double-tree","podcastDeepLink":"https://www.podbean.com/pu/pbblog-72vny-ff93ba","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":15,"gmtAdjustment":"GMT-05:00","useDaylightTime":1,"value":-5,"text":"(GMT-05:00) Eastern Time (US & Canada)","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"America/New_York"},"podcastDownloads":null,"totalEpisodes":11,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Drug Discovery News","engagementStatsBaseUrl":null,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-72vny-ff93ba-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/us/podcast/ddn-dialogues/id1697022169","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png","title":null},{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2FDDNDialogues.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog16749498%26podcastIdTag%3D72vny&dfl=https%3A%2F%2FDDNDialogues.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/1ufZrKqvqdC9U4Vl23EAam","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null},{"name":"Amazon Music","link":"https://music.amazon.com/podcasts/4eefeb8c-8a76-48d1-852b-bc806f5fd892","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/AmazonMusic.png","title":null},{"name":"iHeartRadio","link":"https://iheart.com/podcast/118839386","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/iHeartRadio.png","title":null},{"name":"PlayerFM","link":"https://player.fm/series/3493032","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/PlayerFM.png","title":null},{"name":"Samsung","link":null,"image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/Samsung.png","title":"Search the podcast title on Samsung Podcast app."},{"name":"Podchaser","link":"https://www.podchaser.com/podcasts/ddn-dialogues-5392726","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/Podchaser.webp","title":null}],"components":{"base":[{"id":"MainStyle","val":"dark"},{"id":"Font","val":"Oswald"},{"id":"SecondaryFont","val":"PT Sans"},{"id":"PlayerColor","val":"#FFBE00"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#ffffff"},{"id":"HomeHeaderBackgroundColor","val":"#131430"},{"id":"BackgroundImage","val":"https://mcdn.podbean.com/mf/web/yyxf9g/Picture3.png"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"SecondaryPageBackgroundImage","val":"/assets/doubletree-episode-dark.jpg"},{"id":"SecondaryPageBackgroundImageForMobile","val":null}],"episode-list":[{"id":"EpisodeListType","val":"list"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#ffffff"},{"id":"NavigationBackgroundColor","val":"#000000"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/6jRp9LTzDun3","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-3ANVwzSMoSJx","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer1"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2023 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":null,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://ddndialogues.podbean.com","apiCommonParams":{"t":"673ee9db","clientSignature":"5fca137f68a5bf8404f9195c99a9260b","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb23098840-u7bcp","episode":{"id":"pb23098840","idTag":"u7bcp","title":"From warhead to cancer-killer, the quest for more actinium-225","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16749498/DDN_podcast_logo_ssmzvz_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog16749498/DDN_podcast_logo_ssmzvz_1200x628.jpg?s=27a59704f67e969acb2a07b39efb09cc&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16749498/DDN_podcast_logo_ssmzvz.jpg","previewContent":null,"content":"

Actinium-225 is a radioactive isotope that kills cancer cells with a burst of alpha particles, but it was difficult to make enough of it — until now.

https://www.drugdiscoverynews.com/from-warhead-to-cancer-killer-the-quest-for-more-actinium-225-15934

","publishTimestamp":1715140800,"duration":1732,"mediaUrl":"https://mcdn.podbean.com/mf/web/usdwu9ywsdjidhfx/07_DDN_Dialogues_April_2024_actinium_mixdown_050624_v1ank3s.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-u7bcp-16075d8","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-u7bcp-16075d8","transcriptUrl":null,"permalink":"/e/from-warhead-to-cancer-killer-the-quest-for-more-actinium-225/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PB16075D8U7BCP","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":321,"status":"publish","hasMoreContent":false,"chaptersUrl":null},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-u7bcp-16075d8","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb23098840","idTag":"u7bcp","title":"From warhead to cancer-killer, the quest for more actinium-225","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16749498/DDN_podcast_logo_ssmzvz_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog16749498/DDN_podcast_logo_ssmzvz_1200x628.jpg?s=27a59704f67e969acb2a07b39efb09cc&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog16749498/DDN_podcast_logo_ssmzvz.jpg","previewContent":null,"content":"

Actinium-225 is a radioactive isotope that kills cancer cells with a burst of alpha particles, but it was difficult to make enough of it — until now.

https://www.drugdiscoverynews.com/from-warhead-to-cancer-killer-the-quest-for-more-actinium-225-15934

From warhead to cancer-killer, the quest for more actinium-225

Comments (0)